Latest News in the pharma Industry

Top Stories

Bosch Packaging Technology to Acquire Eisai's Machinery Business

Bosch Packaging Technology to Acquire Eisai's Machinery Business

14 Feb 2012

Bosch Packaging Technology is to acquire Eisai’s machinery business to strengthen its position in the pharmaceutical market.

Read more 
Elan Reports Fourth Quarter and Full-Year 2011 Results

Elan Reports Fourth Quarter and Full-Year 2011 Results

10 Feb 2012

Total revenue for the full-year 2011 increased by 19% to $1,068.1 million, from $895.6 million for the full-year 2010.

Read more 
Bend Research Licenses Spray-dried Dispersion Tech to Lilly

Bend Research Licenses Spray-dried Dispersion Tech to Lilly

10 Feb 2012

This technology is designed to improve the bioavailability of compounds with low aqueous solubility and has been applied to hundreds of compounds at various stages of development.

Read more 
Promega develops new assay to test cytotoxicity levels

Promega develops new assay to test cytotoxicity levels

10 Feb 2012

Promega Corporation says its new assay is more flexible than alternatives.

Read more 
PAREXEL Expands Global Clinical Logistics Services

PAREXEL Expands Global Clinical Logistics Services

9 Feb 2012

The new facilities expand on the company’s existing clinical logistics infrastructure throughout North America, Latin America, Europe, Africa and the Asia/Pacific region.

Read more 
Illumina Rejects Roche's Unsolicited Tender Offer

Illumina Rejects Roche's Unsolicited Tender Offer

8 Feb 2012

Illumina's Board of Directors determined that the $44.50 per share cash offer is grossly inadequate in multiple respects, dramatically undervalues Illumina and is contrary to the best interests of Illumina's stockholders.

Read more 
GlaxoSmithKline Reports Full Year Results 2011

GlaxoSmithKline Reports Full Year Results 2011

8 Feb 2012

The underlying pharmaceuticals growth came from new products, partly offset by generic competition to older products in the US and Europe and the increased impact of European austerity measures.

Read more 
Merck Serono Inks Licensing Deal with Threshold Pharmaceuticals for Cancer Drug

Merck Serono Inks Licensing Deal with Threshold Pharmaceuticals for Cancer Drug

7 Feb 2012

Merck will obtain co-development and exclusive global commercialisation rights, whilst Threshold will retain the option to co-commercialise TH-302 in the US.

Read more 
GSK to Expand Manufacturing Capacity at Australian Plant

GSK to Expand Manufacturing Capacity at Australian Plant

7 Feb 2012

GlaxoSmithKline will invest A$60m to expand its manufacturing and new drug development activities in Australia.

Read more 
Melbourn Scientific Appoints Operations Director

Melbourn Scientific Appoints Operations Director

6 Feb 2012

UK's Melbourn Scientific has appointed laboratory manager, Derek Solomon, as operations director.

Read more 
Syntagon Announces Addition of Quality Assurance Expert

Syntagon Announces Addition of Quality Assurance Expert

6 Feb 2012

Syntagon announced that George K?llner, a Quality Assurance expert, has joined the company.

Read more 
Swiss RohnerChem Forms Partnership with German Evocatal

Swiss RohnerChem Forms Partnership with German Evocatal

6 Feb 2012

RohnerChem and evocatal have announced partnership for enzymatic chemistry development and upscaling.

Read more